Consolidated Balance Sheets - USD ($)
$ in Thousands |
Dec. 31, 2021 |
Dec. 31, 2020 |
| Current assets |
|
|
| Cash and cash equivalents |
$ 26,415
|
$ 7,233
|
| Accounts receivable, net |
6,341
|
4,400
|
| Inventory, net |
14,214
|
5,857
|
| Prepaid expenses |
4,673
|
1,846
|
| Total current assets |
51,643
|
19,336
|
| Property and equipment, net |
65
|
64
|
| Total assets |
51,708
|
19,400
|
| Current liabilities: |
|
|
| Senior notes payable |
42,269
|
41,902
|
| Accounts payable |
13,945
|
12,107
|
| Accrued expenses |
8,261
|
4,631
|
| Deferred revenue |
1,585
|
1,172
|
| Total current liabilities |
66,060
|
59,812
|
| Convertible notes payable to related parties |
0
|
77,911
|
| Royalty obligation |
0
|
9,262
|
| Derivative warrant liability |
1,567
|
0
|
| Total liabilities |
67,627
|
146,985
|
| Commitments and contingencies (See Note 12) |
|
|
| Redeemable convertible preferred stock, $0.001 par value, 0 and 53,340,636 shares authorized at December 31, 2021 and December 31, 2020, respectively; 0 and 36,756,498 shares issued and outstanding at December 31, 2021 and December 31, 2020, respectively |
0
|
198,195
|
| Stockholders' deficit: |
|
|
| Preferred stock, $0.0001 par value; 10,000,000 shares authorized; no shares issued and outstanding at December 31, 2021 and December 31, 2020, respectively |
0
|
0
|
| Common stock $0.0001 par value; 125,000,000 shares authorized; 24,025,817 and 0 shares issued and outstanding at December 31, 2021 and December 31, 2020, respectively |
2
|
0
|
| Additional paid-in capital |
305,734
|
0
|
| Accumulated deficit |
(321,655)
|
(325,780)
|
| Total stockholders' equity (deficit) |
(15,919)
|
(325,780)
|
| Total liabilities, redeemable convertible preferred stock, and stockholders' deficit |
$ 51,708
|
$ 19,400
|